A Handbook Of Health Economic Statistics
By Renee J. G. Arnold Dr. Arnold is currently President and CEO of Arnold Consultancy & Technology LLC, with
headquarter offices in New York City, where she develops and oversees research and affiliated software for the
pharmaceutical, biotech, and device industry and federal government programs.
Economic issues related to the health sector have been gaining much attention in recent years, and the challenge of providing quality and comprehensive health care to a growing population has become increasingly complex. This book’s aim is to introduce readers to basic principles of economics and to a set of analytical tools of economic evaluations and their application in the health sector. The most important evaluation techniques are explained by examples: cost-minimization analysis, cost-effectiveness analysis, cost-utility analysis and cost-benefit analysis.
by: Al Lewis This book introduces a unique viewpoint to population health outcomes measurement: Results/ROIs should be presented as
they are, not as we wish they would be.
The Humble Economist is an outstanding collection of 21 of the most important essays by Prof Tony Culyer, a founding father of health economics. The book is divided into five themes and the essays are written to be easily accessible to a general audience.
An Introduction to the Concepts, Methods and Pitfalls of Health Economic Evaluations by Lieven Annemans
‘Bad Science’ hilariously exposed the tricks that quacks and journalists use to distort science, becoming a 400,000 copy bestseller. Now Ben Goldacre puts the $600bn global pharmaceutical industry under the microscope. What he reveals is a fascinating, terrifying mess.
Statistical Questions in Evidence-based Medicine is a book of questions and answers about the statistical principles and methods used in medical research. Based entirely on material published in the medical literature and popular media, it will prove invaluable to medical students, doctors, nurses, medical researchers and others concerned with medical data.
By Dr. Vijay Pabbathi, presents evidence for how prescription drugs are causing more deaths than natural disasters, challenges the validity of EBM, and suggests that drugs are turning healthy people into sick individuals.
by Ruth Whittington (Kindle Edition - 3 Aug 2009) - Kindle eBook. Buy: £5.19
by Ruth Whittington (Kindle Edition - 1 Jun 2009) - Kindle eBook. Buy: £6.17
by Ruth Whittington (Kindle Edition - 6 Aug 2012) - Kindle eBook. Buy: £8.04
by Ruth Whittington (Kindle Edition - 1 Apr 2008) - Kindle eBook. Buy: £8.04
Medical technology broadly defined to include all aspects of the process of treating disease (e.g., pharmaceuticals, medical devices, and surgical procedures) is profoundly important for individual health and, consequently, also for general welfare. Advances in medical technology convey the prospect of both improved population health and increased general welfare. However, because of the extensive regulation of the markets for healthcare goods and services, the development and application of medical technologies differs fundamentally from non-medical technological advances. This book presents papers that provide theoretical and empirical evidence about the market for medical technology.
by Ruth Whittington (Kindle Edition - 1 Aug 2012) - Kindle eBook. Buy: £8.04
Book by Marya Zilbergerg. Every day we hear conflicting news about health. Last week wine killed; today it saves you from a heart attack.
What does it really mean when the headlines shout "EAT CHOCOLATE, LOSE WEIGHT" or "ABANDON MAMMOGRAPHY"? Between the Lines arms you with the right tools to get under the hood of medical information.
In the new book Unaccountable: What Hospitals Won't Tell You and How Transparency Can Revolutionize Health Care, Dr. Marty Makary explores how the accountability in healthcare would expose dangerous doctors, reward good performance, and force positive change nationally, using the power of the free market
by Jones & O'Donnell. The purpose of this book is to give readers convenient access to a collection of recent contributions that contain innovative applications of microeconometric methods to data on health and health care.
This book reviews the relationship between health technology assessment and policy-making, and examines how to increase the contribution such research makes to policy- and decision-making processes. (by Garrido, Marcial Velasco, et.al)
How do drug companies set prices and what does it mean for patients? Why do governments increasingly get involved, and what is its impact on the global competitive environment? How can an industry that produces life saving drugs have a poorer public reputation than gun and tobacco industries that produce products that kill? Ed Schoonveld, a leading expert and consultant in global pharmaceutical pricing and market access issues, explains how pharmaceutical prices are determined in a complex global player environment and what factors influence the process. His insights will help a wide range of audiences from healthcare industry professionals to policy makers and the broader public to gain a better understanding of this highly complex and emotionally charged field.